CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions		3 Months Ended		6 Months Ended
		Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2021	Dec. 31, 2020
Net Sales		$ 20,953	$ 19,745	$ 41,291	$ 39,063
Cost of Products Sold		10,664	9,253	21,029	18,395
Selling, General and Administrative Expense		5,121	5,112	10,071	10,007
Operating Income		5,168	5,380	10,191	10,661
Interest Expense		(106)	(143)	(215)	(279)
Interest Income		10	9	21	19
Other Non-operating Income/(Loss), Net		167	(369)	277	(227)
Earnings/(Loss) from Continuing Operations Before Income Taxes		5,239	4,877	10,274	10,174
Income Taxes on Continuing Operations		997	990	1,906	1,979
Net Earnings		4,242	3,887	8,368	8,195
Net Income (Loss) Attributable to Noncontrolling Interest		19	33	33	64
Net Income (Loss) Attributable to Parent		$ 4,223	$ 3,854	$ 8,335	$ 8,131
Basic Net Earnings Per Common Share
Basic Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.72	$ 1.53	$ 3.39	$ 3.22
Diluted Net Earnings Per Common Share
Diluted Net Earnings/(Loss) Per Common Share	[1],[2]	$ 1.66	$ 1.47	$ 3.27	$ 3.10
Diluted Weighted Average Common Shares Outstanding		2,544.2	2,615.4	2,551.6	2,620.4

[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.